MedTrace Logo

Effect of 8-week Supplementation With Black Chokeberry on Recovery in Highly Trained Rowers

NCT06133751 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2024-04-26

No results posted yet for this study

Summary

Purpose: To analyze the effects of 8-week supplementation with anthocyanin compounds contained in black chokeberry (Aronia melanocarpa) on indicators of inflammation and oxidative stress.

Hypothesis: Supplementation with anti-inflammatory and antioxidant anthocyanin compounds improves recovery from intense exercise by reducing inflammation and oxidative stress in highly trained rowers

The study consisted of a nutritional intervention (supplementation) - with compounds of natural origin - chokeberry extract (capsules) - 18% standardized for anthocyanin content (dose 3 x 200 mg per day) - that is, 107 mg of pure anthocyanins per day, or a placebo product that was made from chokeberry fiber

Study plan I term of the study

1. Conduct a body composition analysis, body height, food diary, self reported gastrointestinal scale
2. Collection of blood samples before the exercise test for biochemical determinations.
3. Exercise test of 2000m on a rowing ergometer.
4. Collection of blood immediately after exercise and 1 hours after
5. Collection of blood for biochemical determinations 24 hours after the end of the exercise test
6. Supplementation for 8 weeks 2nd test date Repeat the measurements from the 1st test date.

Participants: Youth National Rowing Team of Poland Experimental procedure: Observation of the effect of black chokeberry consumption on parameters of inflammation, oxidative stress and intestinal parameters during the immediate start preparation period in highly skilled rowers.

Conditions

  • Inflammation;Muscle(S)
  • Oxidative Stress Injury
  • Permeability; Increased

Interventions

DRUG

black chokeberry (Aronia melanocarpa)

Black chokeberry capsules standardized for anthocyanin compounds

DRUG

Placebo

Chokeberry fiber placebo capsules

Sponsors & Collaborators

  • Poznan University of Physical Education

    lead OTHER

Principal Investigators

  • Anna Skarpańska-Stejnborn, Professor · Poznan University of Physical Education

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
24 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2023-06-10
Completion
2023-06-10

Countries

  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06133751 on ClinicalTrials.gov